|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparative value of tumor grade,hormonal receptors, Ki-67, HER-2 and topoisomerase Ⅱ alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 2 | Biocompatible flow sensor with integrated solvent concentration measurement显示文摘 | VELTEN T KNOLL T HABERER W | 2008 | Sensors and Actuators A:Physical2008，，： | 1 |
| 3 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase lI alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracyeline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 4 | Comparative value of turaour grade, hormonal receptors, Ki- 67, HER- 2 and topoi- somerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthraeycline-based chemo- therapy显示文摘 | PETIT T WILT M VELTEN M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 5 | Comparative value of turnout grade, hormonal receptors, Ki - 67, HER - 2 and topoisomerase Ⅱ α status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline - based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 6 | Comparative value of tumor grade,hormaonal receptors,Ki67,HER-2 and topoisomerase 11 alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，： | 1 |
| 7 | Comparative value oftumour grade, hormonal receptors, Ki-67, HER-2 and topoi-somerase II alpha status as predictive markers in breast canc-er patients treated with neoadjuvant anthracycline-basedchemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，： | 1 |
| 8 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase 11 alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 9 | Standard SAR ATR evaluation experiment using the MSTAR public release data set显示文摘 | Ross T D Worrell S W Velten V J | 1998 | Algorithms for SAR Imagery V Proc SPIE1998，3370，： | 1 |
| 10 | Inaetivatlon d Eta 1 transcription factor by a specific decoy strategy reduces rat C6 $1ioma cell proliferation and romp-9 expression显示文摘 | SAHIN A VELTEN M PIEISCH T e al | 2005 | Int J Mol Med2005，15，： | 1 |
| 11 | Packaging of Bio --MEMS: Strategies, Technologies, and Applications显示文摘 | Velten T Ru{ H H Barrow D | 2005 | IEEE Transactions on Advanced Packaging2005，28，4： | 1 |
| 12 | Comparative value of tumour grade,hormonal receptors,Ki-67,HER-2 and topoisomerase II alphastatus as predictive markers in breast cancer patients treated withneoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 13 | Standard SAR ATR evaluation experiment using the MSTAR public release data set显示文摘 | Ross T Worrell S Velten V | 1998 | Proceeding of SPIE1998，3370，： | 1 |
| 14 | Comparatlve value of turnout grade, hormonal reeeptors,Ki-67,HER2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 15 | Comparative value of tumor grade,hormonal receptors,Ki-67,Her-2 and topoisomerase Ⅱ a status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T WiltM Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 16 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase I1 al- pha status as predictive markers in breast cancer patients treated with neoadjuvant anthracyeline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 17 | Comparative value of tumour grade,hormonal receptors,Ki-67,HER2 and topoisomerase Ⅱ alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 18 | Standard SAR ATR evaluation experiments using the MSTAR public release data set显示文摘 | ROSS T WORRELL S VELTEN V | 1998 | Proc SPIE1998，3370，： | 1 |
| 19 | Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase Ⅱalpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy 显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，2： | 1 |
| 20 | Comparative value of tumour grade,hormonal receptors,Ki-67,HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy显示文摘 | Petit T Wilt M Velten M | 2004 | Eur J Cancer2004，40，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员